Ligand Based Pharmacophore Modeling and Virtual Screening Studies to Design Novel HDAC2 Inhibitors

Figure 5

The pharmacophore overlay of hit compounds: (a) NSC108392, (b) NSC127064, (c) NSC110782, (d) NSC748337, (e) MFCD01935795, (f) MFCD00830779, (g) MFCD00661790, and (h) MFCD00124221.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)